Carbapenem-resistantKlebsiella pneumoniaesepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbapenem-resistantKlebsiella pneumoniaesepsis in corticosteroid receipt mice: tigecycline or colistin monotherapy versus tigecycline/colistin combination
Authors
Keywords
-
Journal
JOURNAL OF CHEMOTHERAPY
Volume 26, Issue 5, Pages 276-281
Publisher
Informa UK Limited
Online
2013-11-05
DOI
10.1179/1973947813y.0000000143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of carbapenem-resistantKlebsiella pneumoniae: the state of the art
- (2013) Nicola Petrosillo et al. Expert Review of Anti-Infective Therapy
- Bactericidal Activity of Multiple Combinations of Tigecycline and Colistin against NDM-1-Producing Enterobacteriaceae
- (2012) Mahableshwar Albur et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
- (2012) M. Tumbarello et al. CLINICAL INFECTIOUS DISEASES
- Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria
- (2012) M. Akova et al. CLINICAL MICROBIOLOGY AND INFECTION
- Bacteraemia due to OXA-48-carbapenemase-producing Enterobacteriaceae: a major clinical challenge
- (2012) C. Navarro-San Francisco et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinically Relevant Plasma Concentrations of Colistin in Combination with Imipenem Enhance Pharmacodynamic Activity against Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula
- (2011) Phillip J. Bergen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy of Imipenem for the Treatment of Bacteremia Due to an OXA-48-Producing Klebsiella pneumoniae Isolate
- (2011) A.-C. Maherault et al. CLINICAL INFECTIOUS DISEASES
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assay
- (2011) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae
- (2011) G. Meletis et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection
- (2010) Elizabeth B. Hirsch et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
- (2009) Patrice Nordmann et al. LANCET INFECTIOUS DISEASES
- Carbapenem-Hydrolyzing Oxacillinase, OXA-48, Persists in Klebsiella pneumoniae in Istanbul, Turkey
- (2008) Zerrin Aktaş et al. CHEMOTHERAPY
- Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss
- (2008) Dolunay Gülmez et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model
- (2008) Joon Young Song et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
- (2008) A. Poudyal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started